Estradiol Cypionate recalls
The FDA has published 9 recalls involving Estradiol Cypionate since 2013. The latest was reported on 20 Jul 2022. Most were for sterility. Lowlite Investments has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls9since 2013
Last 12 months0reported
Class I00% of total
Ongoing3latest 20 Jul 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 9 100%Class III 0 0%
Why estradiol cypionate is recalled
Companies
By year
Ongoing estradiol cypionate recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Estradiol Cypionate 10mg/mL, a)-vial, b)-vial recalled | TMC Acquisition | Sterility | Nationwide |
| Drug | CLASS II | Estradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml Injection recalled | Lowlite Investments | Sterility | Nationwide |
| Drug | CLASS II | Estradiol Cypionate 10 mg/ml Injection recalled by Lowlite Investments | Lowlite Investments | Sterility | Nationwide |
All estradiol cypionate recalls, newest first
9 totalShould you stop taking Estradiol Cypionate?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.